Press Releases

FLINT, Mich., Aug. 9, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) today announced that its Board of Directors is reviewing strategic alternatives. 

VAUGHAN, ON, Aug. 9, 2019 /PRNewswire/ - CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX: TRST, NYSE: CTST) today announced that the Company's independent auditor, KPMG LLP, Chartered Professional Accountants ("KPMG"), has informed the Company that effective August 8, 2019, it is withdrawing its report dated

ROCKVILLE, Md., Aug. 9, 2019 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing  therapeutics and pharmaceutical products in China, U.S., and throughout the world, today reported financial results for the second quarter and six months ended

CAMBRIDGE, Mass., Aug. 9, 2019 /PRNewswire/ -- Leap Therapeutics, Inc. (NASDAQ: LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today reported financial results for the second quarter ended June 30, 2019."We recently presented positive data from our clinical study of DKN-01 plus KEYTRUDA whic

JERUSALEM, Aug. 9, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces financial results for the three and six months ended June 30, 2019.   Highlights of the second quarter 2019 and recent weeks include: Completed the qualif

CHESTERFIELD, Mo., Aug. 9, 2019 /PRNewswire/ -- Reliv International, Inc. (NASDAQ:RELV), a maker of nutritional supplements that promote optimal health, today reported its financial results for the second quarter of 2019 and announced the formal launch of its RLV line of hemp-extract products at its recent distributor conference in suburban

NEW HAVEN, Conn., Aug. 8, 2019 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN, the "Company"), a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological and neuropsychiatric diseases, today reported financial results for the quarter ended June 30, 2019, and pro

SYDNEY, Aug. 9, 2019 /PRNewswire/ -- The iQ Group Global is honoured to be recognised as one of Australia and New Zealand's Top 5 Most Innovative Companies by The Australian Financial Review and BOSS Magazine in its

SMITHS FALLS, ON, Aug. 9, 2019 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED), (NYSE: CGC) is pleased to announce that it has entered into an agreement to acquire the global cannabinoid-based medical researcher Beckley Canopy Therapeutics ("Beckley Canopy"). The acquisition brings together Canopy's wholly owned research prog

BROOMFIELD, Colo., Aug. 9, 2019 /PRNewswire/ -- A multidisciplinary/interdisciplinary group of orthobiologics experts from the fields of orthopedic surgery, sports medicine, physical medicine and rehabilitation, pain medicine, and interventional spine have embarked on a Delphi panel process to set treatment standards for patients receiving a same day stem cell proc